Northwestern University Feinberg School of Medicine

Cognitive Neurology and Alzheimer's Disease Center

Future of the CNADC

Northwestern Medicine recently announced an initiative to raise $10 million to provide much needed additional space for the Cognitive Neurology and Alzheimer's Disease Center in a setting designed to integrate clinical with basic research. The plan calls for the naming of the center after M.-Marsel Mesulam, MD, the founder and current director of the CNADC. This initiative will allow for the center's growth as it moves into its next phase of leading-edge research and patient care. The creation of an environment wherein researchers, clinicians, and social service staff can conduct work side by side will bolster both communication and collaboration.

"Multidisciplinary integration is essential for addressing Alzheimer’s disease, primary progressive aphasia, and related disorders," said Dr. Mesulam. “The new space will allow basic science laboratories of the CNADC to be located next door to laboratories for imaging and cognitive testing. Faculty from different disciplines will work collaboratively, learn from each other, and train the next generation of clinicians and investigators. The custom-built space will enable a much needed expansion of the research enterprise so that our patients can ultimately become the beneficiaries of the progress,” he said.

The initiative will also focus on raising endowment support that will aid in the recruitment of an additional leader in neurodegenerative maladies who will be able to carry forward the groundbreaking vision of Dr. Mesulam into the future. The horizon of the CNADC holds even greater potential through the growth of its endowment as well as the continuation of annual gifts to research that support daily activities.

The First Extraordinary Commitment

The future of the CNADC is made brighter by the opportunity to endow the center in perpetuity, and Linda and Craig Grannon have made an extraordinary investment in this future by making the first commitment to kick off the initiative. “Marsel’s leadership and positioning of the CNADC form the bridge between the patient care and research components of the center, which is unique to the CNADC. Both of these aspects are so important as they work in partnership with one another,” said Mr. Grannon, who is a former chair of the CNADC Advisory Board. “Our personal and familial experience with the devastating effects of Alzheimer’s disease makes the research and care going on at the CNADC very important to us."

"Craig was a transformative chair of the CNADC Advisory Board, and I continue to consult with him when in need of critical advice,” shared Dr. Mesulam. “I was truly honored and thrilled to learn that Craig and Linda made this commitment to advance the work of the faculty and staff of our center.”

The initiative will also focus on raising endowment support that will aid in the recruitment of additional faculty.

To learn more about how you can support the initiative to endow the CNADC, please contact Courtney Weeks at 312-503-3080 or